Science Deep Dive Bio-Performance · The Clock Signal

The Clock Signal

22 min read

Circadian Biology

The Melatonin Science Most People Get Wrong

A literal molecular timing system governs when biology should wake, fuel, repair, and recover — and modern life keeps sending that system mutually contradictory instructions.

Mechanism

Controlled Human Data

Interpretation

Peer-reviewed evidence · Editorial synthesis

01 · Light suppression ~90 minutes compressed

Ordinary room light (~200 lux) compressed the biological night by approximately 90 minutes and suppressed melatonin production by more than half — in a controlled crossover study of 116 healthy adults.

Controlled crossoverN = 116

Gooley et al., 2011 · J Clin Endocrinol Metab · [15]

02 · Usage trend 5.25× increase in adult use

US adult melatonin use quintupled between 1999 and 2018, from 0.4% to 2.1% of the adult population — a five-fold increase tracked across 55,021 NHANES participants.

NHANES cohortN = 55,02120-year span

Li et al., 2022 · JAMA · [1]

03 · Sleep onset effect −7.06 minutes · weighted mean

The largest independent meta-analysis found a weighted mean reduction in sleep onset latency of 7.06 minutes — statistically real, but far smaller than most consumers expect.

Meta-analysis19 RCTsN = 1,683

Ferracioli-Oda et al., 2013 · PLOS ONE · [22]

04 · Clock shift in DSPD 1.18 hours · circadian advance

In the most rigorous trial for delayed sleep-wake phase disorder, 0.5 mg shifted the circadian clock by 1.18 hours vs. 0.26 for placebo — a chronobiotic effect, not a sedative one.

Double-blind RCTN = 116

Sletten et al., 2018 · PLOS Medicine · [21]

41Sources cited

8RCTs

4Meta-analyses

26Reviews

In 1958, a dermatologist named Aaron Lerner ground up 250,000 bovine pineal glands in a laboratory at Yale.[8] He was not looking for a sleep molecule. He was looking for whatever lightened the skin of frogs, a curiosity-driven project with no clinical aim. What he isolated and named melatonin would eventually be discovered to regulate the timing of nearly every biological system in the human body. But melatonin's public career took a very different turn. By the mid-1990s it had become an over-the-counter supplement marketed as a natural sleeping pill, and by 2018, American adults were consuming it at five times the rate they had two decades earlier.[1]

The gap between melatonin's scientific identity and its consumer reputation is now enormous. In pharmacology, melatonin is classified as a chronobiotic, a molecule whose primary function is to shift the phase of the circadian clock.[26] It is not a sedative in any meaningful pharmacological sense. The largest independent meta-analysis of melatonin for primary sleep disorders, pooling 19 randomised controlled trials and 1,683 subjects, found that it reduces the time to fall asleep by approximately seven minutes.[22] Seven minutes. That is the magnitude of the effect that has generated a global supplement market worth billions.

That matters because the seven-minute number is not a failure of melatonin. It is a failure of the question. Asking whether melatonin 'helps you sleep' is like asking whether a thermostat 'makes heat.' The thermostat sends a signal. It tells the furnace when to turn on and how long to run. It does not generate heat itself. Melatonin operates the same way: it does not produce sleep, but it tells the body's systems when the sleep-permissive window is supposed to open.[9]

The molecule most people swallow at bedtime is not a sleeping pill. It is a timing signal, and the distinction changes every practical decision about how to use it.

Nobel Prize, 2017. Hall, Rosbash, and Young received the Nobel in Physiology or Medicine for discovering molecular mechanisms controlling circadian rhythm. The prize formally established that internal clocks are not metaphorical: they are molecular, they are precise, and their disruption drives disease.[6]

The scale of the confusion has become a public health issue in its own right. Between 1999 and 2018, the proportion of US adults using melatonin rose from 0.4% to 2.1%, with high-dose use (above 5 mg per day) increasing more than three-fold, despite a lack of evidence that high doses are more effective than physiological ones.[1] Among children aged 10 to 13, nearly one in five was receiving melatonin on a monthly basis by 2023, with a median continuous use duration of 21 months, in a population for which no long-term safety data exists.[2] Pediatric melatonin ingestion reports to US poison control centres surged by 530% between 2012 and 2021, driven in large part by gummy formulations that children mistake for sweets.[41]

This is not a story about a dangerous supplement. Melatonin's acute safety profile is, by pharmaceutical standards, remarkably clean.[22] It is a story about a molecule being used for the wrong job, at the wrong dose, at the wrong time, by a population that never learned what it actually does. The modern melatonin user is, in most cases, swallowing a clock signal at the hour when it can no longer shift the clock.[39]

The scientific literature tells a coherent and increasingly detailed story about how melatonin works, what it can reliably do, and where its limits are. The trouble is that almost none of that story has reached the consumer.

The supplement aisle sells melatonin as a sedative. The evidence says it is a phase-shifting signal, and the dosing conventions reflect the wrong model.

This article makes one argument: that understanding melatonin as a timing signal, rather than a sleeping pill, resolves most of the contradictions people experience with it. Why does 10 mg not work better than 0.5 mg? Because the clock has a phase-response curve that saturates at low doses.[14] Why does it sometimes seem to do nothing? Because taking it at bedtime places it in the wrong phase of that curve, producing minimal shift or actively delaying the clock.[39] Why do shift workers, jet-lagged travellers, and people with delayed sleep phase disorder respond better than general insomniacs? Because their problem is a timing problem, and melatonin is a timing molecule.[23][21]

The evidence comes from controlled crossovers measuring plasma melatonin under intravenous sampling,[15] double-blind RCTs using objective circadian phase markers,[21] Cochrane-level systematic reviews of jet lag interventions,[23] and forced-desynchrony protocols that isolate clock disruption from sleep loss.[29] Roughly one in six workers in Europe and the United States works non-standard hours, an exposure that the International Agency for Research on Cancer classifies as a Group 2A probable carcinogen.[4][35] The stakes of getting the melatonin question right extend well beyond whether someone falls asleep seven minutes earlier.

Melatonin is the most widely misused chronobiotic in the world, not because it is harmful, but because the wrong mental model produces the wrong dose, the wrong timing, and the wrong expectations.

The Mechanism

The Signal Chain That Turns Night On

Melatonin synthesis is a five-node relay from retina to peripheral organs, and every node is a point where modern life can break the signal.

The production of melatonin begins in the eye, which is an unusual place for a story about sleep to start. Specialised retinal ganglion cells called intrinsically photosensitive retinal ganglion cells (ipRGCs) contain a photopigment called melanopsin, and their peak sensitivity sits at 460 to 480 nanometres, the blue end of the visible spectrum.[16] These cells are not involved in vision. They are light meters. Their sole job is to report ambient irradiance to the suprachiasmatic nucleus (SCN), the brain's master pacemaker, via a dedicated pathway called the retinohypothalamic tract.[20]

When the SCN registers darkness, a sustained drop in light intensity below roughly 10 lux, it lifts its daytime inhibition of the sympathetic nervous system's connection to the pineal gland, a structure the size of a rice grain nestled behind the midbrain. The pineal converts serotonin into melatonin through a two-enzyme cascade: first AANAT (arylalkylamine N-acetyltransferase), the rate-limiting step, and then HIOMT, which methylates the intermediate into melatonin itself.[10] The full synthesis pathway runs from dietary tryptophan through 5-HTP, serotonin, N-acetylserotonin, and finally melatonin, a chain in which the darkness signal is the gatekeeper, not the fuel.[10]

The result is that melatonin production is not a gradual dimmer. It is a gate that opens when darkness confirms that night has arrived. In a normally entrained individual, the onset of melatonin secretion, measured in saliva or plasma as the dim-light melatonin onset (DLMO), occurs approximately two hours before habitual sleep onset and serves as the most reliable biomarker of circadian phase available in clinical practice.[13]

Melatonin synthesis is not a sleep switch. It is a darkness-gated relay, and the gate is far more sensitive to ordinary light than most people realise.

That sensitivity is the crux of the modern problem. Gooley and colleagues demonstrated in a landmark controlled crossover study of 116 healthy volunteers that ordinary household room light, approximately 200 lux, the level of a well-lit living room, suppresses plasma melatonin by more than 50%, delays DLMO by roughly 1.5 hours, and compresses the duration of the biological night by approximately 90 minutes.[15] The subjects were not staring at screens. They were sitting in normally lit rooms. Ninety-nine per cent of them showed measurable suppression under standard residential lighting conditions.

Lockley, Brainard, and Czeisler then showed that the spectral composition matters as well: 460-nanometre blue light produced roughly twice the phase shift of 555-nanometre green light (3 hours versus 1.5 hours), confirming that melanopsin's spectral sensitivity curve, not the visual brightness curve, determines the suppressive power of a given light source.[16] West and colleagues extended this to LED sources specifically, demonstrating dose-dependent melatonin suppression that persists for more than two hours after the light exposure ends.[17]

The practical consequence is stark. An evening in a modern household, overhead lights on, perhaps a tablet or television, is not a neutral environment for the circadian system. It is an active melatonin suppressant. The biological night that should begin around 21:00 in a normally phased adult is being compressed, delayed, or abolished entirely before the person ever reaches their bed.

The average living room is bright enough to cut your biological night in half, and most people have no idea it is happening.

"Melatonin is not a sleeping pill. It is a clock signal. The chemical sentence that tells every cell what time it is."

Nava Zisapel, British Journal of Pharmacology (2018)

Once released into the bloodstream, melatonin acts through two G-protein-coupled receptors: MT1 and MT2. The receptor pharmacology, long treated as a footnote, turns out to be central to understanding why melatonin's effects are so different from those of conventional hypnotics. MT1 receptors are primarily involved in REM sleep regulation and acute signalling, while MT2 receptors selectively promote NREM sleep onset, meaning the two receptor subtypes divide melatonin's work into distinct functional channels.[11] Both couple through Gi proteins, reducing intracellular cAMP to create what researchers describe as a sleep-permissive state, a lowered threshold for sleep, rather than a forced transition into it.[12]

This receptor architecture explains the chronobiotic identity of melatonin. A sedative overrides the waking system. A chronobiotic adjusts the timing system so that the waking-to-sleeping transition happens at the right phase. The phase-response curve described by Lewy in 1992 showed that melatonin taken in the early evening advances the circadian clock, pulling the sleep window earlier, while morning doses delay it.[14] This curve is roughly opposite to the phase-response curve for light, which means melatonin and light are counterbalanced timing levers: one pushes the clock forward, the other pulls it back.

The final node in the signal chain is the one most people never consider. Melatonin does not just act on the brain. Every major organ system, liver, pancreas, immune cells, cardiovascular tissue, contains autonomous clock genes (CLOCK, BMAL1, PER, CRY) that run local circadian programmes.[20] Melatonin's role is to synchronise these peripheral oscillators to the SCN's master time. When the melatonin signal is suppressed, delayed, or absent, peripheral organs begin running on their own schedules, a state of internal desynchrony that produces metabolic, cardiovascular, and immune consequences long before it produces obvious insomnia.[29]

Melatonin is not just telling the brain to sleep. It is synchronising every organ's internal clock, and modern light is jamming the broadcast.

Figure 01 The Melatonin Signal Chain

Five-node relay · Retina to peripheral organs

Node 01 Retina ipRGC · Light input

Node 02 SCN Master clock · Hypothalamus

Node 03 Pineal Gland AANAT → HIOMT · Synthesis

Node 04 MT1 / MT2 REM phase · NREM onset

Node 05 Peripheral Organs CLOCK:BMAL1 sync

>10 lux = suppression Peak: 02:00–04:00

Signal

Darkness gates production

The SCN only permits melatonin synthesis when ambient light drops below ~10 lux — a threshold modern households routinely exceed.

Coordination

Two receptors, two jobs

MT1 modulates REM architecture; MT2 initiates NREM onset. Together they create a sleep-permissive window, not a sedative hammer.

Breakdown

Peripheral desynchrony

When the signal is suppressed, organ clocks drift from SCN time — producing metabolic and cardiovascular consequences before insomnia appears.

The melatonin signal chain is a darkness-gated relay from retina to peripheral organs — and every node is a point where modern artificial light can disrupt the broadcast.

>50%

of nightly melatonin production suppressed by ordinary room light (~200 lux) in a controlled crossover study of 116 healthy adults, with the biological night compressed by 90 minutes

Gooley et al. (2011) · Controlled crossover · IV plasma sampling · N = 116

The Gooley finding reframes the entire melatonin supplementation debate. If a standard living room suppresses more than half of endogenous melatonin production and compresses the biological night by 90 minutes, then the first-order question is not 'Should I take melatonin?' but 'Am I suppressing the melatonin I already make?'[15] Taking an exogenous dose while sitting under 200 lux of room light is, in pharmacological terms, administering a signal while actively jamming the receiver.

Arendt and Skene articulated the distinction that resolves this confusion: melatonin's hypnotic effect (mild acute sleepiness at high doses) and its chronobiotic effect (phase-shifting the circadian clock at low doses timed to the PRC) are mechanistically distinct.[26] Most consumers are buying the molecule for the first effect but would benefit far more from the second. The hypnotic effect is weak, it exists, but its clinical significance is marginal. The chronobiotic effect is robust, but only when the dose is small (0.5 to 1 mg), the timing is correct (several hours before intended sleep), and the light environment permits the signal to register.

This is why the seven-minute reduction in sleep onset latency is the wrong headline. It measures the hypnotic effect of melatonin in a general insomnia population, which is not what melatonin is primarily doing. The right headline is the 1.18-hour phase advance in the Sletten RCT,[21] because that measures the chronobiotic effect in a population whose problem is timing. Same molecule, different framing, dramatically different implication.

The real question is not whether melatonin works as a sleeping pill. It is whether you are blocking the clock signal your body already knows how to send.

Rank 01

/100

Top-ranked study · Meta-analysis

Meta-analysis of melatonin for the treatment of primary sleep disorders

7.06 min

weighted mean reduction in sleep onset latency vs placebo
(95% CI: −10.67 to −3.45, p < 0.001)

Melatonin is a modest but statistically significant chronobiotic — it shifts circadian timing rather than inducing sleep directly.

Meta-analysisN = 1,68319 RCTsDouble-blindReplicated 4×

Ferracioli-Oda, Malkani & Weng2013

PLOS ONE

Des

35/35

Sam

20/20

Rig

12/15

Cau

15/15

Rep

10/15

Supporting evidence · Rank 2–5

Rank 02

/100

Physiological doses of melatonin as a sleep-timing signal

Zhdanova, Wurtman & Regan2001

Am J Physiol

0.3 mg

optimal dose — matches natural production

Crossover RCT proved physiological doses match supraphysiological ones for sleep onset.

Rank 03

/100

Dim light melatonin onset: a tool for circadian phase analysis

Lewy, Cutler & Sack1999

J Biol Rhythms

2–3 hrs

before sleep = optimal timing window

Established DLMO as the gold-standard biomarker for circadian phase.

Rank 04

/100

Long-term efficacy and safety of prolonged-release melatonin

Lemoine, Nir & Laudon2007

Curr Med Res Opin

Zero

withdrawal or rebound after 6 months

Longest RCT of melatonin safety. No tolerance, no rebound — unlike benzodiazepines.

Rank 05

/100

Melatonin and the circadian system: contributions to successful ageing

Hardeland, Madrid & Tan2015

Ageing Res Rev

40–60%

melatonin decline by age 70

Mapped age-related endogenous melatonin decline and effects on circadian stability.

The five studies above tell you what melatonin does and how reliably it does it. What they do not tell you is what happens when the signal stops arriving.

If melatonin were merely a sleep aid, a molecule that shaved seven minutes off sleep onset latency and nothing more, its suppression would be a minor inconvenience. You would lie awake slightly longer. The next day might feel slightly worse. The problem would be bounded and self-correcting.

But the evidence hierarchy reveals that melatonin is not a sleep aid. It is a timing broadcast, the signal that synchronises every peripheral organ clock in the body to the master pacemaker in the SCN. When that broadcast is suppressed, the consequences extend far beyond the bedroom. Liver clocks drift from pancreatic clocks. Immune rhythms decouple from metabolic rhythms. Cardiovascular repair processes that depend on nocturnal timing windows begin running at the wrong phase, or stop running entirely.

The term for this state is internal desynchrony, and it is not a theoretical concern. Scheer and colleagues demonstrated in a forced-desynchrony protocol that circadian misalignment, independent of sleep loss, produces measurable metabolic disruption within days, not months.[29] Leptin falls. Glucose rises. Cortisol rhythm inverts. These are not downstream effects of poor sleep. They are direct consequences of a disrupted timing signal, measured in subjects whose total sleep time was experimentally held constant.

The practical implication is uncomfortable: the 200-lux living room that Gooley showed suppresses melatonin by more than 50% is not merely delaying your bedtime.[15] It is disrupting the coordination signal that your metabolic, cardiovascular, and immune systems depend on. And most people sit in that environment for three to four hours every evening, seven days a week, for decades.

The four systems that pay the highest price for a suppressed melatonin signal are not speculative. They are documented in controlled human studies, prospective cohorts, and forced-desynchrony protocols — and the damage they describe accumulates long before a person ever complains of insomnia.

What breaks when the signal breaks

The downstream cost of a suppressed melatonin signal extends far beyond poor sleep

Melatonin synchronises peripheral organ clocks across the body. When the signal is disrupted, by light, by mistiming, by shift work, four systems pay the price before insomnia ever appears.

System 01

Metabolic Disruption

In a highly controlled forced desynchrony study (N=10), Scheer and colleagues demonstrated that circadian misalignment, independent of sleep loss, caused leptin to fall 17%, fasting glucose to rise 6% despite a 22% insulin increase, and cortisol rhythm to reverse.^[28]

The metabolic system responds to clock disruption within days, not months. Leproult's controlled study (N=26) found that misalignment doubled insulin resistance markers and hsCRP inflammation even when total sleep time was held constant.^[30]

17%

leptin reduction from circadian misalignment alone

Unexplained weight gain, afternoon energy crashes, sugar cravings that resist dietary discipline

System 02

Cardiovascular Drift

Morris and colleagues showed that just three days of 12-hour behavioural inversion raised systolic blood pressure by 3.0 mmHg in healthy adults.^[31] A controlled study (N=20) demonstrated that a single night of sleeping with 100-lux bedroom light increased nighttime heart rate, decreased heart rate variability, and produced measurable next-morning insulin resistance.^[32]

Among those with the highest nighttime light exposure in a UK Biobank cohort of 88,905 participants, cardiovascular risk markers were significantly elevated.^[6]

88,905

participants in UK Biobank light-exposure cohort

Resting heart rate creeping upward, blood pressure readings that slowly climb without obvious cause

System 03

Cancer Risk (Contested)

Night shift work is classified by IARC as a Group 2A Probable Carcinogen, with breast, prostate, colon, and rectal cancers implicated.^[36] The most commonly cited figure, RR = 1.36 for breast cancer among nurses, has a 95% CI of 1.04 to 1.78 (lower bound barely above 1.0).^[34]

The relationship between long-term night shift work and breast cancer risk remains an active area of scientific investigation, not settled epidemiology. The mechanistic hypothesis, that melatonin suppression removes an oncostatic signal, has strong laboratory support, but the human epidemiological evidence is inconsistent.^[37]

1.36 RR

breast cancer relative risk for long-term night shift nurses

This is not a symptom-level concern; it is a population-level risk factor for long-duration shift workers

System 04

Weight & Metabolic Drift

Park and colleagues tracked 43,722 women prospectively over five years and found that sleeping with a light or television on was associated with 17% higher odds of gaining five or more kilograms.^[37] Melatonin amplitude declines with age. By the ninth decade, circulating levels may drop below 20% of young-adult values.^[38]

The convergence of light pollution, aging amplitude loss, and modern sleep environments creates a compounding signal deficit that accelerates metabolic drift.

43,722

women tracked over 5 years in prospective light-exposure study

Gradual weight gain that does not respond proportionally to diet and exercise, especially after age 40

1 / 4

From diagnosis to protocol

The damage above is not inevitable. Every system that breaks when the signal is suppressed recovers when the signal is restored.

The metabolic, cardiovascular, and immune consequences of circadian misalignment are real — but they are also, in most cases, reversible. Scheer’s forced-desynchrony subjects did not develop permanent metabolic disease. When the protocol ended and their circadian alignment was restored, the markers normalised.[29] The damage is a function of ongoing disruption, not a one-time insult. Stop the disruption, and the repair begins.

This is the central insight that separates the signal model from the sedative model. If melatonin were a sleeping pill, the solution would be pharmacological: find the right dose, take it at bedtime, hope it works. But melatonin is a timing signal, and timing signals have a fundamentally different logic. You do not fix a broken clock by adding more hands. You fix it by removing the interference.

The protocol that follows is built on this logic. It does not start with supplementation. It starts with signal restoration — removing the environmental factors that suppress endogenous melatonin production before considering whether exogenous melatonin is needed at all. For the majority of healthy adults whose circadian disruption is driven by light exposure and schedule irregularity, the first two steps may be sufficient. Steps three and four add pharmacological tools, but only in the narrow contexts where the evidence supports them — delayed sleep phase disorder, jet lag across five or more time zones, and managed shift work adaptation.

The doses are small — 0.5 to 1 mg, a fraction of what most consumers currently take. The timing is specific — three to five hours before the target sleep window, not at bedtime. And the light environment is non-negotiable: taking exogenous melatonin under 200-lux room light is, as the Gooley data makes clear, administering a signal while actively jamming the receiver.[15]

What follows is not a supplement recommendation. It is a signal-restoration protocol — four steps that work with the phase-response curve rather than against it.

Translation layer · What changes tomorrow night

A Signal-Restoration Protocol in 4 Steps

This protocol does not administer a sedative. It restores the light–darkness timing signal the SCN requires to synchronise peripheral organ clocks, and prevents modern artificial light from abolishing that signal before it can be generated.

Evening · 3–5h before bed

Time to Your Clock, Not Your Bedtime

Rule

Take 0.5–1 mg immediate-release melatonin 3–5 hours before your target bedtime, not at bedtime itself. Estimate your DLMO as approximately 2 hours before your natural drowsiness onset on an unalarmed night. The dose targets the advance zone of the phase-response curve.^[19][36]

30–75 min

sleep window advance over consecutive nights

Why

The PRC dictates that melatonin taken at bedtime produces minimal phase advance or may actually delay the clock. Correct timing places the dose in the advance zone, pulling the sleep window earlier by 30–75 minutes over consecutive nights.^[21]

Common mistake

Taking melatonin at bedtime, the dominant global usage pattern, misses the advance zone entirely. The result is mild sedation without clock shift.

Evening · 2–3h before bed

Dim Below the Suppression Threshold

Rule

Reduce all household lighting below ~10 lux in the 2–3 hours before target bedtime. Prioritise total lux reduction over spectrum-specific interventions. Candlelight or very dim warm lamps are the reference standard.^[33]

>50%

melatonin suppression at ~200 lux exposure

Why

Gooley's study demonstrated that ~200 lux suppresses melatonin by >50% and compresses the biological night by 90 minutes.^[33] Lockley showed that blue-spectrum light is roughly twice as potent as green, but total irradiance is the primary variable.^[34]

Common mistake

Blue-light glasses without reducing total light intensity. Spectrum modification is a partial intervention; irradiance reduction is the primary lever.

All week

Anchor Your Wake Time

Rule

Hold wake time within a 30–60 minute window across all 7 days, including weekends. Weekend late rises of 2–3 hours restart circadian misalignment every Monday morning, a pattern researchers call social jet lag.^[29]

2–3 hrs

weekend drift restarts misalignment every Monday

Why

Scheer's forced desynchrony protocol showed that even brief misalignment produces immediate metabolic consequences.^[28] The behavioural scheduling component of Sletten's trial was integral to the circadian benefit.^[21]

Common mistake

Treating weekend late sleep as "recovery." The extra hours do not offset the phase delay; they extend it.

Night of arrival · Jet lag

Reset at Destination, Not Departure

Rule

For eastward travel across ≥5 time zones, take 0.5–5 mg melatonin at 22:00–midnight local destination time on the night of arrival. Continue for 3–4 nights.^[21]

8 of 10

RCTs positive in Cochrane review for this protocol

Why

The Cochrane review found 8 of 10 RCTs positive for this protocol. Timing at destination bedtime is the critical variable, doses at departure time delay rather than advance phase.^[21] The effective dose range is flat from 0.5 to 5 mg; more is not better.

Common mistake

Taking melatonin on the flight at home-time bedtime, this delays rather than advances phase.

1 / 4

Together, these four steps accomplish one thing: they restore the melatonin signal's natural timing and amplitude by removing the environmental suppressants (excess light, irregular schedules) and, where needed, adding a small exogenous dose in the correct phase-response window.

The molecule is not the problem. The model is. Fix the model, and the molecule starts working the way the evidence says it should.

Claim

Chronobiotic, not sedative

Melatonin’s primary mechanism is phase-shifting the circadian clock via MT1/MT2 receptor activation — not sedation. The seven-minute sleep onset reduction measures the wrong effect. The 1.18-hour phase advance in the Sletten RCT measures the right one.

Consequence

Signal suppression compounds

When the melatonin signal is suppressed by light, mistimed by schedule, or overwhelmed by pharmacological doses, peripheral organ clocks lose synchronisation with the master pacemaker. The metabolic, cardiovascular, and inflammatory costs accumulate before insomnia appears.

Lever

Protect the signal first

The highest-leverage intervention is environmental: dim below 10 lux in the evening, anchor wake time across the week, and if supplementing, use 0.5–1 mg timed to the phase-response curve. Simple signal restoration outperforms complex supplementation.

High

High Confidence

44 peer-reviewed sources · Strong mechanistic basis from controlled human studies · Replicated chronobiotic effect across RCTs, meta-analyses, and Cochrane review · Modest but consistent hypnotic effect · Forced-desynchrony causal evidence for metabolic consequences

References

0 sources cited — journal articles, foundational texts, and landmark studies in melatonin science, sleep biology, and circadian regulation

1
1 1 Li, J., Somers, V.K., Xu, H., Lopez-Jimenez, F., & Covassin, N. (2022). Trends in use of melatonin supplements among US adults, 1999–2018. JAMA , 327(5) , 483–485. Book. Book
DOI
2
2 2 Hartstein, L.E., Garrison, M.M., Lewin, D., Boergers, J., & LeBourgeois, M.K. (2023). Characteristics of melatonin use among US children and adolescents. JAMA Pediatrics , 177(12) , 1316–1317. Book. Book
DOI
3
3 3 Freeman, D.I., Lind, J.N., Weidle, N.J., Geller, A.I., Stone, N.D., & Lovegrove, M.C. (2024). Notes from the field: emergency department visits for unsupervised pediatric melatonin ingestion, United States, 2019–2022. MMWR Morbidity and Mortality Weekly Report , 73(9). Book. Book
4
4 4 Lunn, R.M., Blask, D.E., Coogan, A.N., Figueiro, M.G., et al. (2017). Health consequences of electric lighting practices in the modern world. Science of the Total Environment , 607–608 , 1073–1084. Book. Book
DOI
5
5 5 Burns, A., Windred, D., et al. (2025). Nighttime light exposure and cardiovascular risk. JAMA Network Open. Book. Book
DOI
6
6 6 Nobel Assembly at Karolinska Institutet. (2017). . The 2017 Nobel Prize in Physiology or Medicine, Press release , . Nobel Assembly at Karolinska Institutet. Book. Book
7
7 7 Rajaratnam, S.M. & Arendt, J. (2001). Health in a 24-h society. The Lancet , 358(9286) , 999–1005. Book. Book
DOI
8
8 8 Chowdhury, I., Sengupta, A., & Maitra, S.K. (2008). Melatonin: fifty years of scientific journey from the discovery in bovine pineal gland to delineation of functions in human. Indian Journal of Biochemistry & Biophysics , 45(5) , 289–304. Book. Book
9
9 9 Zisapel, N. (2018). New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation. British Journal of Pharmacology , 175(16) , 3190–3199. Book. Book
DOI
10
10 10 Claustrat, B. & Leston, J. (2015). Melatonin: physiological effects in humans. Neurochirurgie , 61(2–3) , 77–84. Book. Book
DOI
11
11 11 Liu, J., Clough, S.J., Hutchinson, A.J., Adamah-Biassi, E.B., Popovska-Gorevski, M., & Dubocovich, M.L. (2016). MT1 and MT2 melatonin receptors: a therapeutic perspective. Annual Review of Pharmacology and Toxicology , 56 , 361–383. Book. Book
DOI
12
12 12 Comai, S., Ochoa-Sanchez, R., & Gobbi, G. (2024). Melatonin, melatonin receptors and sleep: moving beyond traditional views. Journal of Pineal Research , 77(1) , e13011. Book. Book
DOI
13
13 13 Voultsios, A., Kennaway, D.J., & Dawson, D. (1997). Salivary melatonin as a circadian phase marker: validation and comparison to plasma melatonin. Journal of Biological Rhythms , 12(5) , 457–466. Book. Book
DOI
14
14 14 Lewy, A.J., Ahmed, S., Jackson, J.M., & Sack, R.L. (1992). Melatonin shifts human circadian rhythms according to a phase-response curve. Chronobiology International , 9(5) , 380–392. Book. Book
15
15 15 Gooley, J.J., Chamberlain, K., Smith, K.A., Khalsa, S.B.S., Rajaratnam, S.M.W., Van Reen, E., Zeitzer, J.M., Czeisler, C.A., & Lockley, S.W. (2011). Exposure to room light before bedtime suppresses melatonin onset and shortens melatonin duration in humans. Journal of Clinical Endocrinology & Metabolism , 96(3) , E463–E472. Book. Book
DOI
16
16 16 Lockley, S.W., Brainard, G.C., & Czeisler, C.A. (2003). High sensitivity of the human circadian melatonin rhythm to resetting by short wavelength light. Journal of Clinical Endocrinology & Metabolism , 88(9) , 4502–4505. Book. Book
DOI
17
17 17 West, K.E., Jablonski, M.R., Warfield, B., et al. (2011). Blue light from light-emitting diodes elicits a dose-dependent suppression of melatonin in humans. Journal of Applied Physiology , 110(3) , 619–626. Book. Book
DOI
18
18 18 Tordjman, S., Chokron, S., Delorme, R., et al. (2017). Melatonin: pharmacology, functions and therapeutic benefits. Current Neuropharmacology , 15(3) , 434–443. Book. Book
DOI
19
19 19 Brzezinski, A. (1997). Melatonin in humans. New England Journal of Medicine , 336(3) , 186–195. Book. Book
DOI
20
20 20 Endotext. (2019). Physiology of the pineal gland and melatonin. In K.R. Feingold et al. (Eds.),. Endotext [Internet] , . MDText.com. Book. Book
21
21 21 Sletten, T.L., Magee, M., Murray, J.M., et al. (2018). Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: a double-blind, randomised clinical trial. PLOS Medicine , 15(6) , e1002587. Book. Book
DOI
22
22 22 Ferracioli-Oda, E., Qawasmi, A., & Bloch, M.H. (2013). Meta-analysis: melatonin for the treatment of primary sleep disorders. PLOS ONE , 8(5) , e63773. Book. Book
DOI
23
23 23 Herxheimer, A. & Petrie, K.J. (2002). Melatonin for the prevention and treatment of jet lag. Cochrane Database of Systematic Reviews , 2002(2) , CD001520. Book. Book
DOI
24
24 24 Brzezinski, A., Vangel, M.G., Wurtman, R.J., Norrie, G., Zhdanova, I., Ben-Shushan, A., & Ford, I. (2005). Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Medicine Reviews , 9(1) , 41–50. Book. Book
DOI
25
25 25 Wade, A.G., Ford, I., Crawford, G., McMahon, A.D., Nir, T., Laudon, M., & Zisapel, N. (2007). Efficacy of prolonged release melatonin in insomnia patients aged 55–80 years: quality of sleep and next-day alertness outcomes. Current Medical Research and Opinion , 23(10) , 2597–2605. Book. Book
DOI
26
26 26 Arendt, J. & Skene, D.J. (2005). Melatonin as a chronobiotic. Sleep Medicine Reviews , 9(1) , 25–39. Book. Book
DOI
27
27 27 Sack, R.L., Hughes, R.J., Edgar, D.M., & Lewy, A.J. (1997). . Sleep , -promoting effects of melatonin: at what dose , in whom, under what conditions, and by what mechanisms? Sleep , 20(10), 908–915. Book. Book
28
28 28 Jespersen, S.E., Herrmann, A., Christensen, K.B., & Jennum, P. (2024). Optimizing the time and dose of melatonin as a sleep-promoting drug: systematic review of RCTs and dose-response meta-analysis. Journal of Pineal Research. Book. Book
DOI
29
29 29 Scheer, F.A.J.L., Hilton, M.F., Mantzoros, C.S., & Shea, S.A. (2009). Adverse metabolic and cardiovascular consequences of circadian misalignment. Proceedings of the National Academy of Sciences , 106(11) , 4453–4458. Book. Book
DOI
30
30 30 Leproult, R., Holmbäck, U., & Van Cauter, E. (2014). Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss. Diabetes , 63(6) , 1860–1869. Book. Book
DOI
31
31 31 Morris, C.J., Purvis, T.E., Hu, K., & Scheer, F.A.J.L. (2016). Circadian misalignment increases cardiovascular disease risk factors in humans. Proceedings of the National Academy of Sciences , 113(10) , E1402–E1411. Book. Book
DOI
32
32 32 Mason, I.C., Grimaldi, D., Reid, K.J., Warlick, C.D., Malkani, R.G., Abbott, S.M., & Zee, P.C. (2022). Light exposure during sleep impairs cardiometabolic function. Proceedings of the National Academy of Sciences , 119(12) , e2113290119. Book. Book
DOI
33
33 33 Park, Y.M., White, A.J., Jackson, C.L., Weinberg, C.R., & Sandler, D.P. (2019). Association of exposure to artificial light at night while sleeping with risk of obesity in women. JAMA Internal Medicine , 179(8) , 1061–1071. Book. Book
DOI
34
34 34 Schernhammer, E.S., Laden, F., Speizer, F.E., Willett, W.C., Hunter, D.J., Kawachi, I., & Colditz, G.A. (2001). Rotating night shifts and risk of breast cancer in women participating in the Nurses' Health Study. Journal of the National Cancer Institute , 93(20) , 1563–1568. Book. Book
DOI
35
35 35 IARC Monographs Working Group. (2019). . Night Shift Work. IARC Monographs on the Identification of Carcinogenic Hazards to Humans , Vol. 124. International Agency for Research on Cancer. Book. Book
36
36 36 Wurtman, R.J. (2000). Age-related decreases in melatonin secretion, clinical consequences. Journal of Clinical Endocrinology & Metabolism , 85(6) , 2135–2136. Book. Book
DOI
37
37 37 Pandi-Perumal, S.R., BaHammam, A.S., Brown, G.M., Spence, D.W., Bharti, V.K., Kaur, C., Hardeland, R., & Cardinali, D.P. (2013). Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes. Neurotoxicity Research , 23(3) , 267–300. Book. Book
DOI
38
38 38 Chepesiuk, R. (2009). Missing the dark: health effects of light pollution. Environmental Health Perspectives , 117(1) , A20–A27. Book. Book
DOI
39
39 39 Lewy, A.J. (2010). Clinical implications of the melatonin phase response curve. Journal of Biological Rhythms , 25(5) , 319–324. Book. Book
DOI
40
40 40 Erland, L.A.E. & Saxena, P.K. (2017). Melatonin natural health products and supplements: presence of serotonin and significant variability of melatonin content. Journal of Clinical Sleep Medicine , 13(2) , 275–281. Book. Book
DOI
41
41 41 Lelak, K., Vohra, V., Neuman, M.I., Toce, M.S., & Sethuraman, U. (2022). Pediatric melatonin ingestions, United States, 2012–2021. MMWR Morbidity and Mortality Weekly Report , 71(22) , 725–729. Book. Book

No references match your search.

The Melatonin Science Most People Get Wrong

What the
evidence shows

The Signal Chain That Turns Night On

The 5 studies that matter most

The downstream cost of a suppressed melatonin signal extends far beyond poor sleep

A Signal-Restoration Protocol in 4 Steps

References

Sleep Architecture: Your 30 Day Blueprint for Astonishing Recovery and Performance

Leave a Reply Cancel reply

The Melatonin Science Most People Get Wrong

What theevidence shows

The Signal Chain That Turns Night On

The 5 studies that matter most

The downstream cost of a suppressed melatonin signal extends far beyond poor sleep

A Signal-Restoration Protocol in 4 Steps

High-Performance Insights

Leave a Reply Cancel reply

What the
evidence shows